NFATC2 and melanoma: Increased expression of Gal-3 in melanoma lesions correlates with tumor progression (76), and Gal-3 activates NFAT1 (77), which also regulates IL-8 and MMP3 expression in melanoma cells, thus promoting a malignant phenotype (78).